Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia

12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine

NCT03777059 ·Status: COMPLETED ·Phase: PHASE3

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

NCT06810505 ·Status: RECRUITING ·Phase: PHASE3

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

NCT03939312 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine

NCT04437433 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

NCT06543914 ·Status: RECRUITING

A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

NCT04686136 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

NCT03855137 ·Status: COMPLETED ·Phase: PHASE3

A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

NCT00156910 ·Status: COMPLETED ·Phase: PHASE3

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 ·Status: RECRUITING

A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults

NCT05989048 ·Status: COMPLETED ·Phase: PHASE3

Neurolens Headache Study

NCT05070767 ·Status: COMPLETED ·Phase: NA

ADX10059 Migraine Prevention Study

NCT00820105 ·Status: TERMINATED ·Phase: PHASE2

Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine

NCT01462812 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults

NCT07261371 ·Status: COMPLETED ·Phase: PHASE1

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

NCT06241313 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Calcitonin Gene-related Peptide Levels in Chronic Migraine

NCT01071096 ·Status: COMPLETED ·Phase: PHASE4

Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine

NCT03488563 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

NCT06701526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

NCT05399459 ·Status: COMPLETED ·Phase: PHASE3

A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area

NCT06221267 ·Status: COMPLETED

Continuous Treatment Study of Topiramate in Migraine Participants

NCT01799590 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

NCT06047444 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

NCT02025556 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

NCT01445067 ·Status: COMPLETED ·Phase: PHASE1

A Study of K-645 in the Treatment of Multiple Migraine Attacks

NCT07116499 ·Status: TERMINATED ·Phase: PHASE2